Friday, October 07, 2022
Other SARS-CoV-2 Proteins are Important for Disease Severity, Aside from the Spike
University of Maryland School of Medicine researchers have identified how multiple genes of SARS-CoV-2 affect disease severity, which could lead to new ways in how we develop future vaccines or develop newer treatments. The genes control the immune system of the host, contributing to how fiercely the body responds to a COVID-19 infection.
Thursday, October 06, 2022
Dr. Jason Rose Appointed Associate Dean for Innovation and Physician Science Development
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD announced today that Jason Rose, MD, MBA, has been named Associate Dean for Innovation and Physician Science Development at UMSOM. He will also serve as the Director of Faculty Entrepreneurship. The new positions are part of Dean Gladwin’s goal of strengthening the school’s physician-scientist pipeline and advancing a major effort to foster biomedical start-up companies that are based in academia.
Thursday, September 08, 2022
How Memory of Personal Interactions Declines with Age
One of the most upsetting aspects of age-related memory decline is not being able to remember the face that accompanies the name of a person you just talked with hours earlier. While researchers don’t understand why this dysfunction occurs, a new study conducted at University of Maryland School of Medicine (UMSOM) has provided some important new clues. The study was published on September 8 in Aging Cell.
Wednesday, August 31, 2022
UM School of Medicine Researchers Find Blood Type Linked to Risk of Stroke Before Age 60
A person’s blood type may be linked to their risk of having an early stroke, according to a new meta-analysis led by University of Maryland School of Medicine (UMSOM) researchers. Findings were published today in the journal Neurology. The meta-analysis included all available data from genetic studies focusing on ischemic strokes, which are caused by a blockage of blood flow to the brain, occurring in younger adults under age 60.
Tuesday, August 30, 2022
Effects of Drugs in Mice can Depend on the Sex of the Human Experimenter
University of Maryland School of Medicine researchers demonstrated that a stress response in the brain is essential for ketamine’s antidepressant response in mice suggesting new ways to improve antidepressant therapy for patients who do not respond to the treatment.
Tuesday, August 30, 2022
$800K Donation Will Fund New Discoveries and Treatments for ALS
The University of Maryland School of Medicine (UMSOM) will receive an $800,000 donation to be used by the University of Maryland Brain and Tissue Bank to advance research into the treatment and cure of Amyotrophic Lateral Sclerosis (ALS), commonly referred to as Lou Gehrig’s Disease.
Wednesday, August 24, 2022
UM School of Medicine Study Finds a New Way to Optimize Treatment Success for Fecal Transplants
Fecal transplants have been successful in treating serious diarrheal infections but have often failed when tried with other diseases. Up until now, no one could predict why these treatments sometimes failed to help restore healthy bacteria in the colon. Researchers from the University of Maryland School of Medicine’s (UMSOM) Institute for Genome Sciences (IGS) have discovered important clues that could lead more personalized approaches to optimize treatment success. They published their findings in Cell Reports Medicine online earlier this month.
Thursday, August 18, 2022
Senior Academic Leader and Internationally Recognized Scientist Christopher P. O'Donnell, PhD, Appointed Vice Dean for Research Development and Operations at UM School of Medicine
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD announced today that Christopher P. O’Donnell, PhD, Associate Vice Chancellor for Emerging Technologies in Health Sciences Education at the University of Pittsburgh, has been named Vice Dean for Research Development and Operations at the UMSOM, effective September 1, 2022. Dr. O’Donnell, who has led the integration of diverse digital technology learning initiatives across Pitt Health Sciences, joins Dean Gladwin as part of UMSOM’s senior leadership team. Dr. Gladwin began his tenure as Dean at UMSOM on August 1.
Friday, August 12, 2022
Off and Running: In First Week, Dean Gladwin is Already Making His Mark
Full Week of Events Signals His Values and Priorities for UMSOM and His Commitment to Taking on Our Greatest Global Health Challenges
Wednesday, August 10, 2022
University of Maryland School of Medicine Faculty Share $13 Million Funding Award to Study Fracture Prevention Strategies for Osteoporosis
University of Maryland School of Medicine (UMSOM) faculty from the Department of Epidemiology & Public Health and the Department of Physical Therapy and Rehabilitation Science are co-recipients of a $13 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to compare interventions used to improve mobility and prevent future fractures in older adults recovering from a hip or leg fracture. The 5-year study is being conducted by researchers at UMSOM and Brigham and Women’s Hospital in Boston in partnership with ProMedica, a large integrated healthcare network with skilled nursing facilities across the United States.